New pathway to reduce toxicity of α-Synuclein
Categories
Parkinson’s disease, α-Synuclein, Brain lipids
Development Stage
Proof of concept demonstrated
Patent Status
Provisional patent application filed
Market
Parkinson’s Disease is a ...
Novel approach using low molecular weight antioxidants
Categories
CNS, Cardiovascular, Inflammation, NAC-amide (AD4)
Development Stage
Successful toxicology studies completed for AD4
Patent Status
Patents filed in Australia and United ...
Novel treatment for Parkinson’s disease overcomes “on-off” phenomenon
Categories
Parkinson’s disease, L-dopa, L-dopa amide
Development Stage
Concept proven, in vivo human models
Patent Status
Pending patent application in, Europe, US ...
Department of Microbiology and Molecular Genetics, Faculty of Medicine, ophryp@ekmd.huji.ac.il, 972-2-675-7203
IMRIC
Institute for Medical Research Israel-CanadaResearch Hub Goals and Activities
To develop collaborations with industry ...
IMRIC
Institute for Medical Research Israel-CanadaScientific Background
In animals, neurons working together as a nervous system are responsible for the ability to perceive and respond appropriately to environmental changes.
Sensory ...
We have invented a novel framework and methods for the optimal selection and placement of anatomical and fiducial landmarks for image-guided neurosurgery. The method computes the rigid registration transformation that minimizes the Target ...
Show better therapeutic activity
Categories
Formulation, Oncology / Cancer
Development Stage
Early stages – cell culture tests
Patent Status
Filed in the US
Market
The global market for cancer drugs is expected to grow 12-15% annually ...
Additional material on the technology can be supplied upon request
Additional material on the technology can be supplied upon request
Additional material on the technology can be supplied upon request
Immunomodulatory peptides derived from Japanese rice
Categories
Peptide, Small Molecule, Inflammatory/Autoimmune diseases
Development Stage
Proof of concept in MS mouse model
Patent Status
Patent filed in the United States
Market ...
Additional material on the technology can be supplied upon request
Commercial Advantages:
An individual stereoisomer of valnoctamide (VCD - I) or propylisopropyl acetamide (PID- II), has the potential to become better and superior to the commercially available racemic VCD (a mixture of four stereoisomers). The ...
B11 is effective in treating inflammatory diseases with no side effects
Categories
Anti-inflammatory, small molecule
Development Stage
In vivo results
Patent Status
Publication no: WO05080414A1, WO06001011A1Highlights
The B11 peptide is ...
Additional material on the technology can be supplied upon request
Additional material on the technology can be supplied upon request
Additional material on the technology can be supplied upon request
add
